RAGE-229

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameRAGE-229
Drug Alias NameRAGE-229
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdvanced glycosylation end product-specific receptor antagonists
TargetsAdvanced glycosylation end product-specific receptor
Therapy Area/IndicationsDiabetes Complications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNyu Langone Health
China Registration ClassN/A

Develop Information

Active CompaniesNyu Langone Health
Inactive CompaniesN/A
Active IndicationsDiabetes Complications
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A